Asia-Pacific Patient Monitoring Market by Product (Cardiac Monitoring Devices, Blood Glucose Monitoring Systems, Hemodynamic/Pressure Monitoring Devices, Multi-parameter Monitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Weight Monitoring Devices, and Other Devices), by Type (Conventional and Wireless), and by End User (Home Healthcare, Hospitals & Clinics, and Others) - Opportunity Analysis and Industry Forecast, 2024–2030

Asia-Pacific Patient Monitoring Market

Industry:  Life Sciences & Healthcare | Publish Date: Feb 2024 | No of Pages:  188 | No. Tables:  135 | No. Figures:  100

Market Definition

Asia-Pacific Patient Monitoring Market size was valued at USD 9.94 billion in 2023, and is predicted to reach USD 17.34 billion by 2030, with a CAGR of 7.9% from 2024 to 2030. Patient monitoring is a vital component of contemporary healthcare, encompassing the ongoing or intermittent observation of a patient's essential signs, physiological parameters, and general health condition throughout their medical treatment. This procedure utilizes a variety of medical devices and technologies to gather, record, and analyze data such as blood pressure, heart rate, oxygen saturation, respiratory rate, temperature, and other vital signs.

The patient monitoring market refers to the healthcare industry segment dedicated to creating, manufacturing, and distributing equipment and systems for consistently or periodically monitoring and recording a patient's essential signs and health parameters. It plays a critical role in a wide range of healthcare settings, from hospitals and intensive care units to outpatient clinics and home healthcare. This ensures that patients receive the appropriate level of care tailored to their individual medical needs.

Rising Aging Population Creates Demand for Patient Monitoring Systems

The Asia-Pacific region is undergoing a significant demographic shift marked by a notable increase in its elderly population. This demographic trend brings with it a higher prevalence of chronic health conditions commonly associated with aging, such as diabetes, cardiovascular problems, and respiratory disorders. With the aging population facing complex health challenges, the demand for continuous and proactive monitoring has surged. Patient monitoring systems, adept at tracking vital signs and providing early detection of health issues, have become pivotal in addressing the healthcare needs of the elderly. This demographic factor serves as a primary driver for the growth of the patient monitoring market in the Asia-Pacific region.

 

Government Initiatives Drives the Growth of Patient Monitoring Industry

Government initiatives in the Asia-Pacific region are pivotal drivers for the growth of the patient monitoring market. Recognizing the significance of a robust healthcare system, governments allocate funds to enhance healthcare infrastructure, including hospitals and clinics, facilitating the integration of advanced technologies including patient monitoring systems. Initiatives often encourage the adoption of modern healthcare technologies through incentives and favorable regulatory environments, fostering collaboration between the public and private sectors.

These efforts aim to improve accessibility to healthcare services, especially in underserved areas, through the deployment of mobile health units and telehealth services. Clear regulatory frameworks and public health campaigns further support the safe and effective use of patient monitoring technologies, educating the public about the benefits of regular health monitoring.

 

Connectivity Issues in Patient Monitoring Devices Restrain the Market Growth

One of the significant restraining factors in the patient monitoring market in Asia-Pacific is the connectivity issues which pose a risk to real-time data transmission and communication between devices, impacting the timeliness and accuracy of patient information. Addressing these challenges is crucial for unlocking the full potential of patient monitoring technologies and ensuring their widespread adoption in the healthcare sector.

Advent of AI and Machine Learning in Patient Monitoring Systems Create Growth Opportunities

Artificial Intelligence (AI) and Machine Learning (ML) are transforming the landscape of patient monitoring by enabling advanced analysis of extensive datasets. In this context, AI algorithms leverage historical patient data to identify subtle patterns and anomalies in vital signs and medical history. This capability allows for early detection of potential health issues before symptoms manifest, facilitating timely interventions.

Moreover, the integration of AI and ML supports the concept of personalized medicine, tailoring treatment plans based on individual patient characteristics and responses. These technologies contribute to risk stratification, helping healthcare providers prioritize interventions for patients at higher risk of developing specific medical conditions or complications.

Japan Holds the Dominant Market Share in Asia-Pacific Patient Monitoring Market

Japan is experiencing a significant increase in the prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and respiratory diseases. Chronic conditions often require continuous monitoring to manage and control symptoms effectively. Patient monitoring devices, ranging from wearable sensors to sophisticated diagnostic equipment, play a pivotal role in the ongoing assessment of patients with these health issues.

Technological advancements constitute a significant driving force in the Patient Monitoring Market in Japan. This involves the integration of modern technologies, such as wireless and wearable devices, which enable continuous and non-intrusive monitoring of vital signs. The application of data analytics and artificial intelligence enhances the processing of vast datasets, allowing for accurate predictions and early detection of health abnormalities.

India to Witness Substantial Growth in the Asia-Pacific Market 

Government initiatives in India are pivotal drivers of the growth in the Patient Monitoring Market. The Indian government has committed substantial investments to upgrade healthcare infrastructure, establishing new medical facilities, and procuring advanced medical equipment, including patient monitoring systems. Initiatives such as the National Health Mission (NHM) and Ayushman Bharat aim to improve healthcare accessibility and delivery, with a focus on incorporating digital health solutions.

Increasing healthcare awareness in India is a pivotal driver for the Patient Monitoring Market. As awareness among healthcare professionals and the public expands, there is a heightened understanding of the crucial role continuous health monitoring plays in early disease detection and management. This shift towards proactive healthcare is driving demand for patient monitoring systems, with healthcare providers actively educating patients on the benefits of real-time data collection and analysis for improved health outcomes.

 

Competitive Landscape

Various market players operating in the Asia-Pacific patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Nihon Kohden Corporation, Abbott Laboratories, Masimo Corporation, Hill-Rom Holdings, Inc., Biotronik SE & Co. KG, Honeywell International, Inc., and others.

Asia-Pacific Patient Monitoring Key Market Segments

By Product

  • Cardiac Monitoring Devices

    • Mobile Cardiac Telemetry Monitors

    • Electrocardiogram (ECG) Devices

    • Implantable Loop Recorders

    • Event Monitors

    • Smart/Wearable ECG Monitors

  • Blood Glucose Monitoring Systems

    • Self-Monitoring Blood Glucose Systems

    • Continuous Glucose Monitoring Systems

  • Hemodynamic/Pressure Monitoring Devices

    • Hemodynamic Monitors

    • Blood Pressure Monitors

    • Disposables 

  • Multi-Parameter Monitoring Devices

    • Low-Acuity Monitoring Device

    • Mid-Acuity Monitoring Devices

    • High-Acuity Monitoring Devices

  • Respiratory Monitoring Devices

    • Pulse Oximeters

    • Spirometers

    • Capnographs

    • Peak Flow Meters

  • Temperature Monitoring Device

    • Handheld Temperature Monitoring Devices

    • Table-Top Temperature Monitoring Devices

    • Wearable Continuous Monitoring Devices

    • Invasive Temperature Monitoring Devices

    • Smart Temperature Monitoring Devices

  • Fetal & Neonatal Monitoring Devices

    • Neonatal Monitoring Devices

    • Fetal Monitoring Devices

  • Neuromonitoring Devices

    • Electroencephalograph (EEG) Machines

    • Electromyography Machines

    • Cerebral Oximeter

    • Intracranial Pressure (ICP) Monitors

    • Magnetoencephalography (MEG) Machines

    • Transcranial Doppler (TCD) Machines

  • Weight Monitoring Devices

    • Digital

    • Analog

  • Others Devices

By Type

  • Conventional

  • Wireless

By End User

  • Home Healthcare

  • Hospitals & Clinics

  • Others

By Region

  • Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Indonesia

    • Singapore

    • Rest of Asia-Pacific

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 9.94 Billion

Revenue Forecast in 2030

USD 17.34 Billion

Revenue Growth Rate

CAGR of 7.9% from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Billion (USD)

Growth Factors

Increasing Aging Population creates Demand for Patient Monitoring Industry in Asia-Pacific

Government Initiatives Drives the Growth of Patient Monitoring in Asia-Pacific

Countries Covered

7

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Test

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      ASIA-PACIFIC PATIENT MONITORING MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6      ASIA-PACIFIC PATIENT MONITORING MARKET BY PRODUCT

           6.1      OVERVIEW

           6.2      CARDIAC MONITORING DEVICES

                         6.2.1      CARDIAC MONITORING DEVICES MARKET, BY PRODUCT

                                          6.2.1.1      MOBILE CARDIAC TELEMETRY MONITORS MARKET, BY COUNTRY

                                          6.2.1.2      ELECTROCARDIOGRAM (ECG) DEVICES MARKET, BY COUNTRY

                                          6.2.1.3      IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY

                                          6.2.1.4      EVENT MONITORS MARKET, BY COUNTRY

                                          6.2.1.5      SMART/WEARABLE ECG MONITORS MARKET, BY COUNTRY

                         6.2.2      CARDIAC MONITORING DEVICES MARKET, BY COUNTRY

           6.3      BLOOD GLUCOSE MONITORING SYSTEMS

                         6.3.1      BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

                                          6.3.1.1      SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COUNTRY

                                          6.3.1.2      CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY

                         6.3.2      BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY

           6.4      HEMODYNAMIC/PRESSURE MONITORING DEVICES

                         6.4.1      HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY PRODUCT

                                          6.4.1.1      HEMODYNAMIC MONITORS MARKET, BY COUNTRY

                                          6.4.1.2      BLOOD PRESSURE MONITORS MARKET, BY COUNTRY

                                          6.4.1.3      DISPOSABLES MARKET, BY COUNTRY

                         6.4.2      HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY COUNTRY

           6.5      MULTI-PARAMETER MONITORING DEVICES

                         6.5.1      MULTI-PARAMETER MONITORING DEVICES MARKET, BY PRODUCT

                                          6.5.1.1      LOW-ACUITY MONITORING DEVICE MARKET, BY COUNTRY

                                          6.5.1.2      MID-ACUITY MONITORING DEVICES MARKET, BY COUNTRY

                                          6.5.1.3      HIGH-ACUITY MONITORING DEVICES MARKET, BY COUNTRY

                         6.5.2      MULTI-PARAMETER MONITORING DEVICES MARKET, BY COUNTRY

           6.6      RESPIRATORY MONITORING DEVICES

                         6.6.1      RESPIRATORY MONITORING DEVICES MARKET, BY PRODUCT

                                          6.6.1.1      PULSE OXIMETERS MARKET, BY COUNTRY

                                          6.6.1.2      SPIROMETERS MARKET, BY COUNTRY

                                          6.6.1.3      CAPNOGRAPHS MARKET, BY COUNTRY

                                          6.6.1.4      PEAK FLOW METERS MARKET, BY COUNTRY

                         6.6.2      RESPIRATORY MONITORING DEVICES MARKET, BY COUNTRY

           6.7      TEMPERATURE MONITORING DEVICE

                         6.7.1      TEMPERATURE MONITORING DEVICE MARKET, BY PRODUCT

                                          6.7.1.1      HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY

                                          6.7.1.2      TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY

                                          6.7.1.3      WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY COUNTRY

                                          6.7.1.4      INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY

                                          6.7.1.5      SMART TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY

                         6.7.2      TEMPERATURE MONITORING DEVICE MARKET, BY COUNTRY

           6.8      FETAL AND NEONATAL MONITORING DEVICES

                         6.8.1      FETAL AND NEONATAL MONITORING DEVICES MARKET, BY PRODUCT

                                          6.8.1.1      NEONATAL MONITORING DEVICES MARKET, BY COUNTRY

                                          6.8.1.2      FETAL MONITORING DEVICES MARKET, BY COUNTRY

                         6.8.2      FETAL AND NEONATAL MONITORING DEVICES MARKET, BY COUNTRY

           6.9      NEUROMONITORING DEVICES

                         6.9.1      NEUROMONITORING DEVICES MARKET, BY PRODUCT

                                          6.9.1.1      ELECTROENCEPHALOGRAPH (EEG) MACHINES MARKET, BY COUNTRY

                                          6.9.1.2      ELECTROMYOGRAPHY MACHINES MARKET, BY COUNTRY

                                          6.9.1.3      CEREBRAL OXIMETER MARKET, BY COUNTRY

                                          6.9.1.4      INTRACRANIAL PRESSURE (ICP) MONITORS MARKET, BY COUNTRY

                                          6.9.1.5      MAGNETOENCEPHALOGRAPHY (MEG) MACHINES MARKET, BY COUNTRY

                                          6.9.1.6      TRANSCRANIAL DOPPLER (TCD) MACHINES MARKET, BY COUNTRY

                         6.9.2      NEUROMONITORING DEVICES MARKET, BY COUNTRY

           6.10      WEIGHT MONITORING DEVICES

                         6.10.1      WEIGHT MONITORING DEVICES MARKET, BY PRODUCT

                                          6.10.1.1      DIGITAL MARKET, BY COUNTRY

                                          6.10.1.2      ANALOG MARKET, BY COUNTRY

                         6.10.2      WEIGHT MONITORING DEVICES MARKET, BY COUNTRY

           6.11      OTHERS DEVICES

                         6.11.1      OTHERS DEVICES MARKET, BY COUNTRY

7      ASIA-PACIFIC PATIENT MONITORING MARKET BY TYPE

           7.1      OVERVIEW

           7.2      CONVENTIONAL

                         7.2.1      CONVENTIONAL MARKET, BY COUNTRY

           7.3      WIRELESS

                         7.3.1      WIRELESS MARKET, BY COUNTRY

8      ASIA-PACIFIC PATIENT MONITORING MARKET BY END USER

           8.1      OVERVIEW

           8.2      HOME HEALTHCARE

                         8.2.1      HOME HEALTHCARE MARKET, BY COUNTRY

           8.3      HOSPITALS AND CLINICS

                         8.3.1      HOSPITALS AND CLINICS MARKET, BY COUNTRY

           8.4      OTHERS

                         8.4.1      OTHERS MARKET, BY COUNTRY

9     ASIA-PACIFIC PATIENT MONITORING MARKET, BY COUNTRY

           9.1     OVERVIEW

           9.2     AUSTRALIA

                         9.2.1     ASIA-PACIFIC PATIENT MONITORING MARKET, BY PRODUCT

                         9.2.2     ASIA-PACIFIC PATIENT MONITORING MARKET, BY TYPE

                         9.2.3     ASIA-PACIFIC PATIENT MONITORING MARKET, BY END USER

           9.3     CHINA

                         9.3.1     ASIA-PACIFIC PATIENT MONITORING MARKET, BY PRODUCT

                         9.3.2     ASIA-PACIFIC PATIENT MONITORING MARKET, BY TYPE

                         9.3.3     ASIA-PACIFIC PATIENT MONITORING MARKET, BY END USER

           9.4     INDIA

                         9.4.1     ASIA-PACIFIC PATIENT MONITORING MARKET, BY PRODUCT

                         9.4.2     ASIA-PACIFIC PATIENT MONITORING MARKET, BY TYPE

                         9.4.3     ASIA-PACIFIC PATIENT MONITORING MARKET, BY END USER

           9.5     JAPAN

                         9.5.1     ASIA-PACIFIC PATIENT MONITORING MARKET, BY PRODUCT

                         9.5.2     ASIA-PACIFIC PATIENT MONITORING MARKET, BY TYPE

                         9.5.3     ASIA-PACIFIC PATIENT MONITORING MARKET, BY END USER

           9.6     SOUTH KOREA

                         9.6.1     ASIA-PACIFIC PATIENT MONITORING MARKET, BY PRODUCT

                         9.6.2     ASIA-PACIFIC PATIENT MONITORING MARKET, BY TYPE

                         9.6.3     ASIA-PACIFIC PATIENT MONITORING MARKET, BY END USER

           9.7     INDONESIA

                         9.7.1     ASIA-PACIFIC PATIENT MONITORING MARKET, BY PRODUCT

                         9.7.2     ASIA-PACIFIC PATIENT MONITORING MARKET, BY TYPE

                         9.7.3     ASIA-PACIFIC PATIENT MONITORING MARKET, BY END USER

           9.8     SINGAPORE

                         9.8.1     ASIA-PACIFIC PATIENT MONITORING MARKET, BY PRODUCT

                         9.8.2     ASIA-PACIFIC PATIENT MONITORING MARKET, BY TYPE

                         9.8.3     ASIA-PACIFIC PATIENT MONITORING MARKET, BY END USER

           9.9     REST OF ASIA-PACIFIC

                         9.9.1     ASIA-PACIFIC PATIENT MONITORING MARKET, BY PRODUCT

                         9.9.2     ASIA-PACIFIC PATIENT MONITORING MARKET, BY TYPE

                         9.9.3     ASIA-PACIFIC PATIENT MONITORING MARKET, BY END USER

10   COMPANY PROFILES

           10.1   MEDTRONIC PLC

                         10.1.1   COMPANY OVERVIEW

                         10.1.2   COMPANY SNAPSHOT

                         10.1.3   OPERATING BUSINESS SEGMENTS

                         10.1.4   PRODUCT PORTFOLIO

                         10.1.5   BUSINESS PERFORMANCE

                         10.1.6   BUSINESS SEGMENTS

                         10.1.7   GEOGRAPHIC SEGMENTS

                         10.1.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.1.9   PRIMARY MARKET COMPETITORS

           10.2   KONINKLIJKE PHILIPS N.V.

                         10.2.1   COMPANY OVERVIEW

                         10.2.2   COMPANY SNAPSHOT

                         10.2.3   OPERATING BUSINESS SEGMENTS

                         10.2.4   PRODUCT PORTFOLIO

                         10.2.5   BUSINESS PERFORMANCE

                         10.2.6   BUSINESS SEGMENTS

                         10.2.7   GEOGRAPHIC SEGMENTS

                         10.2.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.2.9   PRIMARY MARKET COMPETITORS

           10.3   GE HEALTHCARE

                         10.3.1   COMPANY OVERVIEW

                         10.3.2   COMPANY SNAPSHOT

                         10.3.3   OPERATING BUSINESS SEGMENTS

                         10.3.4   PRODUCT PORTFOLIO

                         10.3.5   BUSINESS PERFORMANCE

                         10.3.6   BUSINESS SEGMENTS

                         10.3.7   GEOGRAPHIC SEGMENTS

                         10.3.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.3.9   PRIMARY MARKET COMPETITORS

           10.4   SIEMENS HEALTHINEERS

                         10.4.1   COMPANY OVERVIEW

                         10.4.2   COMPANY SNAPSHOT

                         10.4.3   OPERATING BUSINESS SEGMENTS

                         10.4.4   PRODUCT PORTFOLIO

                         10.4.5   BUSINESS PERFORMANCE

                         10.4.6   BUSINESS SEGMENTS

                         10.4.7   GEOGRAPHIC SEGMENTS

                         10.4.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.4.9   PRIMARY MARKET COMPETITORS

           10.5   NIHON KOHDEN CORPORATION

                         10.5.1   COMPANY OVERVIEW

                         10.5.2   COMPANY SNAPSHOT

                         10.5.3   OPERATING BUSINESS SEGMENTS

                         10.5.4   PRODUCT PORTFOLIO

                         10.5.5   BUSINESS PERFORMANCE

                         10.5.6   BUSINESS SEGMENTS

                         10.5.7   GEOGRAPHIC SEGMENTS

                         10.5.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.5.9   PRIMARY MARKET COMPETITORS

           10.6   ABBOTT LABORATORIES

                         10.6.1   COMPANY OVERVIEW

                         10.6.2   COMPANY SNAPSHOT

                         10.6.3   OPERATING BUSINESS SEGMENTS

                         10.6.4   PRODUCT PORTFOLIO

                         10.6.5   BUSINESS PERFORMANCE

                         10.6.6   BUSINESS SEGMENTS

                         10.6.7   GEOGRAPHIC SEGMENTS

                         10.6.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.6.9   PRIMARY MARKET COMPETITORS

           10.7   MASIMO CORPORATION

                         10.7.1   COMPANY OVERVIEW

                         10.7.2   COMPANY SNAPSHOT

                         10.7.3   OPERATING BUSINESS SEGMENTS

                         10.7.4   PRODUCT PORTFOLIO

                         10.7.5   BUSINESS PERFORMANCE

                         10.7.6   BUSINESS SEGMENTS

                         10.7.7   GEOGRAPHIC SEGMENTS

                         10.7.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.7.9   PRIMARY MARKET COMPETITORS

           10.8   HILL-ROM HOLDINGS, INC.

                         10.8.1   COMPANY OVERVIEW

                         10.8.2   COMPANY SNAPSHOT

                         10.8.3   OPERATING BUSINESS SEGMENTS

                         10.8.4   PRODUCT PORTFOLIO

                         10.8.5   BUSINESS PERFORMANCE

                         10.8.6   BUSINESS SEGMENTS

                         10.8.7   GEOGRAPHIC SEGMENTS

                         10.8.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.8.9   PRIMARY MARKET COMPETITORS

           10.9   BIOTRONIK SE AND CO. KG

                         10.9.1   COMPANY OVERVIEW

                         10.9.2   COMPANY SNAPSHOT

                         10.9.3   OPERATING BUSINESS SEGMENTS

                         10.9.4   PRODUCT PORTFOLIO

                         10.9.5   BUSINESS PERFORMANCE

                         10.9.6   BUSINESS SEGMENTS

                         10.9.7   GEOGRAPHIC SEGMENTS

                         10.9.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.9.9   PRIMARY MARKET COMPETITORS

           10.10   HONEYWELL INTERNATIONAL, INC.

                         10.10.1   COMPANY OVERVIEW

                         10.10.2   COMPANY SNAPSHOT

                         10.10.3   OPERATING BUSINESS SEGMENTS

                         10.10.4   PRODUCT PORTFOLIO

                         10.10.5   BUSINESS PERFORMANCE

                         10.10.6   BUSINESS SEGMENTS

                         10.10.7   GEOGRAPHIC SEGMENTS

                         10.10.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.10.9   PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 2. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 3. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 4. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 5. EVENT MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 6. SMART/WEARABLE ECG MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 7. CARDIAC MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 8. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 9. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 10. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 11. HEMODYNAMIC MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 12. BLOOD PRESSURE MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 13. DISPOSABLES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 14. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 15. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 16. MID-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 17. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 18. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 19. PULSE OXIMETERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 20. SPIROMETERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 21. CAPNOGRAPHS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 22. PEAK FLOW METERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 23. RESPIRATORY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 24. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 25. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 26. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 27. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 28. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 29. TEMPERATURE MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 30. NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 31. FETAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 32. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 33. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 34. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 35. CEREBRAL OXIMETER, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 36. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 37. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 38. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 39. NEUROMONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 40. DIGITAL, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 41. ANALOG, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 42. WEIGHT MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 43. OTHERS DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 44. ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 45. CONVENTIONAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 46. WIRELESS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 47. ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 48. HOME HEALTHCARE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 49. HOSPITALS AND CLINICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 50. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 51. ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 52. AUSTRALIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 53. AUSTRALIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 54. AUSTRALIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 55. CHINA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 56. CHINA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 57. CHINA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 58. INDIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 59. INDIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 60. INDIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 61. JAPAN ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 62. JAPAN ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 63. JAPAN ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 64. SOUTH KOREA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 65. SOUTH KOREA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 66. SOUTH KOREA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 67. INDONESIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 68. INDONESIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 69. INDONESIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 70. SINGAPORE ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 71. SINGAPORE ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 72. SINGAPORE ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 73. REST OF ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 74. REST OF ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 75. REST OF ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 76. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 77. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS

TABLE 78. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 79. MEDTRONIC PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 80. MEDTRONIC PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 81. MEDTRONIC PLC: KEY STRATERGY

TABLE 82. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 83. KONINKLIJKE PHILIPS N.V.: OPERATING BUSINESS SEGMENTS

TABLE 84. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 85. KONINKLIJKE PHILIPS N.V.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 86. KONINKLIJKE PHILIPS N.V.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 87. KONINKLIJKE PHILIPS N.V.: KEY STRATERGY

TABLE 88. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 89. GE HEALTHCARE: OPERATING BUSINESS SEGMENTS

TABLE 90. GE HEALTHCARE: PRODUCT PORTFOLIO

TABLE 91. GE HEALTHCARE: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 92. GE HEALTHCARE: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 93. GE HEALTHCARE: KEY STRATERGY

TABLE 94. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

TABLE 95. SIEMENS HEALTHINEERS: OPERATING BUSINESS SEGMENTS

TABLE 96. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO

TABLE 97. SIEMENS HEALTHINEERS: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 98. SIEMENS HEALTHINEERS: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 99. SIEMENS HEALTHINEERS: KEY STRATERGY

TABLE 100. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 101. NIHON KOHDEN CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 102. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 103. NIHON KOHDEN CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 104. NIHON KOHDEN CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 105. NIHON KOHDEN CORPORATION: KEY STRATERGY

TABLE 106. ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 107. ABBOTT LABORATORIES: OPERATING BUSINESS SEGMENTS

TABLE 108. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 109. ABBOTT LABORATORIES: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 110. ABBOTT LABORATORIES: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 111. ABBOTT LABORATORIES: KEY STRATERGY

TABLE 112. MASIMO CORPORATION: COMPANY SNAPSHOT

TABLE 113. MASIMO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 114. MASIMO CORPORATION: PRODUCT PORTFOLIO

TABLE 115. MASIMO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 116. MASIMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 117. MASIMO CORPORATION: KEY STRATERGY

TABLE 118. HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT

TABLE 119. HILL-ROM HOLDINGS, INC.: OPERATING BUSINESS SEGMENTS

TABLE 120. HILL-ROM HOLDINGS, INC.: PRODUCT PORTFOLIO

TABLE 121. HILL-ROM HOLDINGS, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 122. HILL-ROM HOLDINGS, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 123. HILL-ROM HOLDINGS, INC.: KEY STRATERGY

TABLE 124. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT

TABLE 125. BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS

TABLE 126. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO

TABLE 127. BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 128. BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 129. BIOTRONIK SE AND CO. KG: KEY STRATERGY

TABLE 130. HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT

TABLE 131. HONEYWELL INTERNATIONAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 132. HONEYWELL INTERNATIONAL, INC.: PRODUCT PORTFOLIO

TABLE 133. HONEYWELL INTERNATIONAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 134. HONEYWELL INTERNATIONAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 135. HONEYWELL INTERNATIONAL, INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

FIGURE 7. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 8. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 9. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 10. EVENT MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 11. SMART/WEARABLE ECG MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 12. CARDIAC MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 13. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 14. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 15. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 16. HEMODYNAMIC MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 17. BLOOD PRESSURE MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 18. DISPOSABLES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 19. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 20. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 21. MID-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 22. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 23. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 24. PULSE OXIMETERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 25. SPIROMETERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 26. CAPNOGRAPHS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 27. PEAK FLOW METERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 28. RESPIRATORY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 29. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 30. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 31. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 32. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 33. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 34. TEMPERATURE MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 35. NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 36. FETAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 37. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 38. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 39. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 40. CEREBRAL OXIMETER, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 41. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 42. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 43. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 44. NEUROMONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 45. DIGITAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 46. ANALOG, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 47. WEIGHT MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 48. OTHERS DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 49. ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

FIGURE 50. CONVENTIONAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 51. WIRELESS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 52. ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 53. HOME HEALTHCARE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 54. HOSPITALS AND CLINICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 55. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 56. ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY REGION 2023-2030, (MILLION USD)

FIGURE 57. AUSTRALIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 58. AUSTRALIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 59. AUSTRALIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 60. CHINA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 61. CHINA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 62. CHINA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 63. INDIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 64. INDIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 65. INDIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 66. JAPAN ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 67. JAPAN ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 68. JAPAN ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 69. SOUTH KOREA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 70. SOUTH KOREA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 71. SOUTH KOREA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 72. INDONESIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 73. INDONESIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 74. INDONESIA ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 75. SINGAPORE ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 76. SINGAPORE ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 77. SINGAPORE ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 78. REST OF ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 79. REST OF ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 80. REST OF ASIA-PACIFIC PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 81. MEDTRONIC PLC: NET SALES, (2021-2023)

FIGURE 82. MEDTRONIC PLC: PRIMARY MARKET COMPETITORS

FIGURE 83. KONINKLIJKE PHILIPS N.V.: NET SALES, (2021-2023)

FIGURE 84. KONINKLIJKE PHILIPS N.V.: PRIMARY MARKET COMPETITORS

FIGURE 85. GE HEALTHCARE: NET SALES, (2021-2023)

FIGURE 86. GE HEALTHCARE: PRIMARY MARKET COMPETITORS

FIGURE 87. SIEMENS HEALTHINEERS: NET SALES, (2021-2023)

FIGURE 88. SIEMENS HEALTHINEERS: PRIMARY MARKET COMPETITORS

FIGURE 89. NIHON KOHDEN CORPORATION: NET SALES, (2021-2023)

FIGURE 90. NIHON KOHDEN CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 91. ABBOTT LABORATORIES: NET SALES, (2021-2023)

FIGURE 92. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS

FIGURE 93. MASIMO CORPORATION: NET SALES, (2021-2023)

FIGURE 94. MASIMO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 95. HILL-ROM HOLDINGS, INC.: NET SALES, (2021-2023)

FIGURE 96. HILL-ROM HOLDINGS, INC.: PRIMARY MARKET COMPETITORS

FIGURE 97. BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)

FIGURE 98. BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS

FIGURE 99. HONEYWELL INTERNATIONAL, INC.: NET SALES, (2021-2023)

FIGURE 100. HONEYWELL INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS

KEY PLAYERS

  • Medtronic Plc

  • Koninklijke Philips N.V.

  • GE Healthcare

  • Siemens Healthineers

  • Nihon Kohden Corporation

  • Abbott Laboratories

  • Masimo Corporation

  • Hill-Rom Holdings, Inc.

  • Biotronik SE & Co. KG

  • Honeywell International, Inc.


Frequently Asked Questions
Which region is dominating the Asia-Pacific patient monitoring market?

Japan contributes to the dominant share of the Asia-Pacific patient monitoring market.

What is the market size of the Asia-Pacific patient monitoring market in 2023?

According to Next Move Strategy Consulting, the market size of Asia-Pacific patient monitoring is USD 9.94 billion in 2023.

What role does artificial intelligence (AI) play in patient monitoring?

AI is used to analyze large datasets from patient monitoring devices, helping healthcare providers detect trends and anomalies and predict patient outcomes effectively.

What are the benefits of using wearable patient monitoring devices?

Wearable patient monitoring devices offer real-time data, improved patient comfort, and the ability to track health metrics continuously, which can aid in early disease detection and management.

Which are the top companies operating in the Asia-Pacific patient monitoring market?

The top companies operating in the Asia-Pacific patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, and Abbott Laboratories.